# Lyell Immunopharma, Inc.: Form DEF 14A, filed Apr 22, 2024

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: DEF 14A
- Filed: 2024-04-22
- Accepted by EDGAR: Apr 22, 2024, 16:15 ET
- Period: 2023-06-14
- Accession: 0001140361-24-021008
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000114036124021008/lyel-20240614.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000114036124021008/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000114036124021008/lyel-20240614.htm

Filed Apr 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-021008. Last ingested by Listed: Nov 4, 2026, 17:25 ET. No prices; not investment advice.